Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model

Multiple myeloma is a malignant still incurable plasma cell disorder. This is due to refractory disease relapse, immune impairment, and development of multi-drug resistance. The growth of malignant plasma cells is dependent on the bone marrow (BM) microenvironment and evasion of the host's anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Zhiwei, Su, Jing, Wu, Dan, Peng, Huiming, Zhao, Weiling, Zhao, Brian Nlong, Zhou, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352350/
https://www.ncbi.nlm.nih.gov/pubmed/28032590
http://dx.doi.org/10.18632/oncotarget.13831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352350/
https://www.ncbi.nlm.nih.gov/pubmed/28032590
http://dx.doi.org/10.18632/oncotarget.13831

Ejemplares similares